Concepedia

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock, Lei Wang, Yibin Liu, Maria‐Luisa Schubert, Brigitte Neuber, Angela Hückelhoven‐Krauss, Ulrike Gern, Anita Schmitt,

Cancer Immunology Immunotherapy · 2019 · 52 citations · 41 references

DOIFull text

Open access

Concepts

References

41

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Richard A. Morgan, Mark E. Dudley, John R. Wunderlich et al. · Science · 2006 · 2.6K citations · Full text

, , +14

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi, Lionel Apétoh, Jenna M. Sullivan et al. · The Journal of Experimental Medicine · 2010 · 2.1K citations · Full text

, , +16

A human memory T cell subset with stem cell–like properties

Luca Gattinoni, Enrico Lugli, Yun Ji et al. · Nature Medicine · 2011 · 1.9K citations · Full text

, , +12

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins, Richard A. Morgan, Steven A. Feldman et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

, , +17

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

Julien Fourcade, Zhaojun Sun, Mourad Benallaoua et al. · The Journal of Experimental Medicine · 2010 · 1.3K citations · Full text

, , +17